{"id":48845,"date":"2022-09-27T12:01:54","date_gmt":"2022-09-27T10:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/"},"modified":"2022-09-27T12:01:54","modified_gmt":"2022-09-27T10:01:54","slug":"2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/","title":{"rendered":"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644482\/global-lung-cancer-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=67qwql&amp;utm_campaign=1755245+-+2022+Global+Lung+Cancer+Clinical+Trial+Pipeline+Highlights+Report%3A+Up-to-date+Information+on+Key+Pipeline+Products+&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report provides the most up-to-date information on key pipeline products within the global Lung Cancer market. It covers emerging therapies for Lung Cancer in active clinical development stages including early and late stage clinical trials.\n<\/p>\n<p>\nThe pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n<p>\n<strong>Clinical Trial Stages:<\/strong>\n<\/p>\n<p>\nThe report provides Lung Cancer pipeline products by clinical trial stages including both early and late stage development &#8211; phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n<p>\n<strong>Drug Mechanism Classes:<\/strong>\n<\/p>\n<p>\nThe report provides Lung Cancer pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n<p>\n<strong>Company:<\/strong>\n<\/p>\n<p>\nThe report provides Lung Cancer pipeline products by the company.\n<\/p>\n<p>\n<strong>Short-term Launch Highlights:<\/strong>\n<\/p>\n<p>\nFind out which Lung Cancer pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n<p>\n<strong>Summary:<\/strong>\n<\/p>\n<ul>\n<li>\nLung Cancer phase 3 clinical trial pipeline products\n<\/li>\n<li>\nLung Cancer phase 2 clinical trial pipeline products\n<\/li>\n<li>\nLung Cancer phase 1 clinical trial pipeline products\n<\/li>\n<li>\nLung Cancer preclinical research pipeline products\n<\/li>\n<li>\nLung Cancer discovery stage pipeline products\n<\/li>\n<li>\nLung Cancer pipeline products short-term launch highlights\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644482\/global-lung-cancer-clinical-trial-pipeline?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=67qwql&amp;utm_campaign=1755245+-+2022+Global+Lung+Cancer+Clinical+Trial+Pipeline+Highlights+Report%3A+Up-to-date+Information+on+Key+Pipeline+Products+&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/yg454c<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;t&#x6f;&#x3a;&#x70;&#114;&#101;s&#x73;&#x40;&#x72;&#101;&#115;e&#x61;&#x72;&#x63;&#104;&#97;n&#x64;&#x6d;&#x61;&#114;ke&#x74;&#x73;&#x2e;&#99;om\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;&#115;&#115;&#64;&#x72;&#x65;&#x73;&#101;&#97;rc&#x68;&#x61;&#x6e;&#100;&#109;a&#x72;&#x6b;&#x65;&#116;&#115;&#46;c&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Lung Cancer market. It covers emerging therapies for Lung Cancer in active clinical development stages including early and late stage clinical trials. The &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48845","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Lung Cancer market. It covers emerging therapies for Lung Cancer in active clinical development stages including early and late stage clinical trials. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-27T10:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-27T10:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/\"},\"wordCount\":297,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005622\\\/en\\\/1583801\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/\",\"name\":\"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005622\\\/en\\\/1583801\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-27T10:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005622\\\/en\\\/1583801\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220927005622\\\/en\\\/1583801\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides the most up-to-date information on key pipeline products within the global Lung Cancer market. It covers emerging therapies for Lung Cancer in active clinical development stages including early and late stage clinical trials. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-27T10:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products &#8211; ResearchAndMarkets.com","datePublished":"2022-09-27T10:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/"},"wordCount":297,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/","name":"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/21\/logo.jpg","datePublished":"2022-09-27T10:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220927005622\/en\/1583801\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/2022-global-lung-cancer-clinical-trial-pipeline-highlights-report-up-to-date-information-on-key-pipeline-products-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"2022 Global Lung Cancer Clinical Trial Pipeline Highlights Report: Up-to-date Information on Key Pipeline Products &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48845"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48845\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}